COVID-19 rapid guideline: managing COVID-19, NICE guideline [NG191] Last updated: 04 October 2021

In October, NICE added new recommendations on casirivimab and imdevimab. New data on the use of heparins (from the REMAP-CAP trial results) does not change the current recommendations.
Source: Current Awareness Service for Health (CASH) - Category: Consumer Health News Source Type: news